LPSN vs NICE vs SPOK vs KORE vs MANH

For growth investors, NICE Ltd.

(NICE) is the stronger pick with 7. 7% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, NICE Ltd.

(NICE) is the cheapest at 9. 9x versus Manhattan Associates, Inc. at 39. 9x. On forward P/E, NICE Ltd. is actually cheaper at 8. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 33x versus Manhattan Associates, Inc. 's 1. 25x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Spok Holdings, Inc.

(SPOK) delivered a total return of +61. 9%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: MANH returned +145. 1% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), KORE Group Holdings, Inc.

(KORE) is the lower-risk stock at -0. 09β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately -2388% more volatile than KORE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 36% for Manhattan Associates, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), NICE Ltd.

(NICE) is pulling ahead at 7. 7% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: LivePerson, Inc. grew EPS 45. 4% year-over-year, compared to 2. 6% for Manhattan Associates, Inc.. Over a 3-year CAGR, MANH leads at 12. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

NICE Ltd.

(NICE) is the more profitable company, earning 20. 8% net margin versus -51. 1% for KORE Group Holdings, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MANH leads at 26. 1% versus -35. 9% for KORE. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 33x versus Manhattan Associates, Inc. 's 1. 25x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NICE Ltd. (NICE) trades at 8. 7x forward P/E versus 26. 8x for Manhattan Associates, Inc. — 18. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 57. 8% to $150. 88.

In this comparison, SPOK (11.

9% yield) pays a dividend. LPSN, NICE, KORE, MANH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Spok Holdings, Inc.

(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 11. 9% yield). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPOK: +13. 3%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (LPSN (Technology) and NICE (Technology) and SPOK (Healthcare) and KORE (Communication Services) and MANH (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: LPSN is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; SPOK is a small-cap deep-value stock; KORE is a small-cap quality compounder stock; MANH is a small-cap quality compounder stock. SPOK pays a dividend while LPSN, NICE, KORE, MANH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.